跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIAMET 20 mg /120 mg artemether/lumefantrine 20 mg/120 mg dispersible tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
RIAMET 20 mg /120 mg artemether/lumefantrine 20 mg/120 mg dispersible tablet blister pack
Approved
STANDARD
RIAMET 20 mg /120 mg artemether/lumefantrine 20 mg/120 mg dispersible tablet blister pack
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
80a05a817b8d82dd
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
80a05a817b8d82dd
Product Name
RIAMET 20 mg /120 mg artemether/lumefantrine 20 mg/120 mg dispersible tablet blister pack
Artg Id
158523
Artg Name
RIAMET 20 mg/120 mg artemether/lumefantrine 20 mg/120 mg dispersible tablet blister pack
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2010-07-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/55cc80f7b32fee4c92a135b386b56185.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c2859243cfd6ed74fc8b6ce249016a84.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
80a05a817b8d82dd
Type
Standard
Back to TGA Approvals